The Center for Pediatric Research (CPR) was created in 2004 to enhance the infrastructure and mentorship programs at Nemours/AIDHC to improve opportunities for investigators to successfully compete for extramural funding. A key component of this infrastructure was the modernization and expansion of research core services. Pediatric diseases are usually distinct from those found in adults, stemming from genetic abnormalities and/or developmental defects. As a small institution, it was critical that the CPR be disease agnostic and broadly drive advancement of multiple pediatric research programs. By modernizing instrumentation and making key recruitments, the CPR transformed a biomolecular core laboratory and a clinical research services core. New cores for cell science/proteomics, bioinformatics, and high throughput screening were also created to enhance the ability of investigators to incorporate multidisciplinary approaches into research. These five COBRE supported cores have considerable institutional support and are now integrated into a research services core with another four core services that are now primarily supported by the institution. The three specific aims of the Research Services Core are as follows:
Specific Aim 1 : To strengthen the existing core infrastructure by integrating research service cores at Nemours/AIDHC;
Specific Aim 2 : To develop strategies to evaluate core efficiency and effectiveness by incorporating continuous improvement (CI) approaches;
and Specific Aim 3 : To develop a long-term plan to ensure that research cores are sustainable and adapt to changes in research needs and funding sources. Building on the successes of COBRE I & II, support is now focused on integrating these nine research service cores in order to optimize best practices for core usage, management and funding. Currently, Nemours is on a journey to improve management processes and customer service by empowering each staff member. A cornerstone of Continuous Improvement (CI) is that the people who do the work are given the opportunity and the power to improve their workflows. In COBRE Phase III, we intend to incorporate CI processes to further develop best practices, thus enhancing core efficiency and usage, thereby establishing a stable revenue stream to ensure core sustainability.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
5P30GM114736-04
Application #
9538205
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Alfred I. Du Pont Hosp for Children
Department
Type
DUNS #
038004941
City
Wilmington
State
DE
Country
United States
Zip Code
19803
Doherty, Caitlin; Averill, Lauren W; Theroux, Mary et al. (2018) Natural history of Morquio A patient with tracheal obstruction from birth to death. Mol Genet Metab Rep 14:59-67
Khan, Shaukat A; Mason, Robert W; Giugliani, Roberto et al. (2018) Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Mol Genet Metab 125:44-52
Phay, Monichan; Kim, Hak Hee; Yoo, Soonmoon (2018) Analysis of piRNA-Like Small Non-coding RNAs Present in Axons of Adult Sensory Neurons. Mol Neurobiol 55:483-494
Peracha, Hira; Sawamoto, Kazuki; Averill, Lauren et al. (2018) Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Mol Genet Metab 125:18-37
Melbouci, Melodie; Mason, Robert W; Suzuki, Yasuyuki et al. (2018) Growth impairment in mucopolysaccharidoses. Mol Genet Metab 124:1-10
Hellbach, Nicole; Peterson, Suzanne; Haehnke, Daniel et al. (2018) Impaired myogenic development, differentiation and function in hESC-derived SMA myoblasts and myotubes. PLoS One 13:e0205589
Butchbach, Matthew E R (2018) Using Systems Biology and Mathematical Modeling Approaches in the Discovery of Therapeutic Targets for Spinal Muscular Atrophy. Adv Neurobiol 21:267-281
Nagao, Kyoko; Morlet, Thierry; Haley, Elizabeth et al. (2018) Neurophysiology of hearing in patients with mucopolysaccharidosis type IV. Mol Genet Metab 123:472-478
Tantzer, Stephanie; Sperle, Karen; Kenaley, Kaitlin et al. (2018) Morpholino Antisense Oligomers as a Potential Therapeutic Option for the Correction of Alternative Splicing in PMD, SPG2, and HEMS. Mol Ther Nucleic Acids 12:420-432
Sawamoto, Kazuki; Chen, Hui-Hsuan; Alméciga-Díaz, Carlos J et al. (2018) Gene therapy for Mucopolysaccharidoses. Mol Genet Metab 123:59-68

Showing the most recent 10 out of 63 publications